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Abstract
Of the vaccinia virus genes that are conserved in all sequenced poxviruses, each one except for VACWR084 (G6R) has been at least partially
characterized. The poxvirus protein encoded by G6R belongs to the NlpC/P60 superfamily, which consists of proteins with a papain-like fold and
known or predicted protease, amidase or acyltransferase activity. The G6 protein was synthesized late in infection and localized to the interior of
virions, primarily between the membrane and core. Unlike other conserved poxvirus genes, G6R was not required for virus propagation and
spread in a variety of cells. Nevertheless, G6R null mutants caused less severe disease in mice than the parent or revertant virus. Moreover,
mutation of the predicted catalytic cysteine led to the same level of attenuation as a null mutant, suggesting that the G6 protein has enzymatic
activity that is important in vivo. Conservation of G6R amongst poxviruses and the disparity between its role in vitro and in vivo imply that the
protein is involved in an aspect of the virus–host interaction that is common to vertebrates and insects.
Published by Elsevier Inc.Keywords: Vaccinia virus G6R gene; Virus pathogenesis; Papain fold; Cysteine–histidine dyadIntroduction
The Poxviridae comprise a large family of complex DNA
viruses that replicate in the cytoplasm of a variety of animals from
insects to mammals (Moss, 2007). The insect poxviruses differ
from vertebrate poxviruses in many aspects of their biology and
genome organization. Accordingly, Poxviridae are classified into
two subfamilies: Chordopoxvirinae and Entomopoxvirinae.
Currently, each of the 8 genera of chordopoxviruses is represented
by one or more complete genome sequences, and two genome
sequences of entomopoxviruses are available as well (www.
poxvirus.org). Comparison of multiple complete poxvirus ge-
nome sequences delineated ∼100 genes that are conserved in all
chordopoxviruses and a subset of the latter (∼50) also present in
entomopoxviruses, ofwhich some are even found in other nucleo-
cytoplasmic large DNA viruses (Iyer et al., 2006; Upton et al.,⁎ Corresponding author.
E-mail address: bmoss@nih.gov (B. Moss).
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2008.01.0092003). The remaining genes (∼100) are specific for different
genera or even species of poxviruses. There is a major functional
distinction between the conserved and the genus/species-specific
genes of poxviruses. The conserved genes show a strong tendency
to be “essential”, i.e., the corresponding knockout mutants are
non-viable in cell culture. By contrast, the non-conserved genes
are mostly non-essential, i.e., are not required for virus replication
in at least some cell lines but contribute to virus–host interactions
and virulence.
Investigations of the functions of conserved genes have
yielded an outline of the poxvirus reproductive cycle. With only
a single exception, those genes that are shared by all poxviruses
have been functionally characterized (albeit at widely varying
level of detail) in vaccinia virus (VACV), the best-studied
member of the family. The only gene in this category that
remains a complete unknown corresponds to the prototype
Western Reserve (WR) strain of VACV gene VACWR084
(henceforth called G6R based on the designation adopted
for the Copenhagen strain of VACV) (Goebel et al., 1990). An
Fig. 1. Multiple alignment of the G6 orthologs from all poxvirus genera and selected closest homologs from prokaryotes. The alignment includes one representative sequence from each genus of Chordopoxvirinae,
unclassified crocodilepox virus and the two complete Entomopoxvirinae sequences. Virus abbreviation, name, and genus are: VAC, WR strain vaccinia virus, Orthopoxvirus; MYX, myxoma virus, Leporipoxvirus;
LSDV, lumpy skin disease virus, Capripoxvirus; SPV, swinepox virus, Suipoxvirus; YMTV, Yaba monkey tumor virus, Yatapoxvirus; ORFV, ORF virus, Parapoxvirus; MCV, molluscum contagiosum virus,
Molluscipoxvirus; FPV, fowlpox virus, Avipoxvirus; CrPV, Crocodilepox virus, unclassified; AMV, Amsacta moorei entomopoxvirus, Entomopoxvirus; MSV, Melanoplus sanguinipes entomopoxvirus, Entomopox-
virus; Gmet (Gmet_0084) is an uncharacterized protein from the bacterium Geobacter metallireducens GS-15; TK (TK1927) is an uncharacterized protein from the archaeon Thermococcus kodakarensis KOD1; Anae
(Anae109_4280) is an uncharacterized protein from the bacterium Anaeromyxobacter sp. Fw109-5; YiiX (YiiX_2IF6) is an uncharacterized protein from E. coli for which the PDB accession code is also indicated.
Columns that contain amino acid residues conserved in the majority of the aligned sequences are shaded grey. The predicted catalytic His and Cys are shown in bold type and denoted by asterisks. The secondary structure
elements displayed under the alignment are from the crystal structure of the YiiX protein of E. coli; s represents β-strand and h represents α-helix; the strands and helices are numbered consecutively as in the PDB.
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Fig. 2. Detection of the G6 protein in infected cells and virus particles. (A) The
portion of the VACV genomemodified by the insertion of a V5-tag at the C-terminus
ofG6R is shown. PG6 andP11 are promoters of theG6R andEGFPgene, respectively.
G5.5R and G7L are genes adjacent to G6R. EGFP expression was used for the
screening of recombinant virus plaques. (B) Western blot analysis of total extracts of
cell infected with vG6-V5/EGFP at different times after infection in the absence or
presence of AraC and of purified vG6-V5/EGFP virions. AraC (40μg/ml) was added
1 h before virus infection and was present continuously thereafter. Only one third of
the cell extract from the 24 h point without AraC was analyzed on the gel to avoid
overloading. Proteins were resolved by SDS-PAGE, transferred to a membrane and
detected by chemiluminescence with anti-V5 antibody conjugated to horseradish
peroxidase or anti-A3 protein antibody followed by anti-rabbit IgG conjugated to
horseradish peroxidase. The higher and lower bands detected by anti-A3 antibody
correspond to unprocessed and processed forms, respectively.
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ferred to as G6) came from another field of research. As part of a
comprehensive computational analysis of proteins involved in
bacterial cell-wall biogenesis and degradation, it has been
shown that G6 and its orthologs from other poxviruses form a
distinct family within the NlpC/P60 superfamily of known and
predicted enzymes (Anantharaman and Aravind, 2003). The
NlpC/P60 superfamily is extremely diverse at the sequence and
taxonomic levels and includes proteins from bacteria, archaea,
bacteriophages, eukaryotes, and their viruses. Most of the pro-
teins of this superfamily have not been experimentally cha-
racterized but several are known to function as peptidases,
amidases or acyltransferases. Secondary structure prediction
and identification of conserved motifs containing invariant
cysteine and histidine residues has led to the identification of a
putative papain-like fold with a catalytic Cys–His dyad in these
proteins (Anantharaman and Aravind, 2003). Considering this
prediction and the inherent interest in the only remaining un-
characterized conserved protein for poxvirus biology, we set out
to characterize the role of the G6 protein in virus reproduction.
Results
G6 is conserved in all poxviruses and belongs to the NlpC/P60
superfamily of enzymes with a circular permutation of the
predicted catalytic domain
The VACVG6R open reading frame encodes a protein of 165
amino acids (18.9-kDa), which is conserved in all poxvirus
genomes sequenced to date (www.poxvirus.org). The alignment
of poxvirus orthologs of the G6 protein shows the conservation
of several distinct motifs including two that center at invariant
His and Cys residues (Fig. 1). It was reported previously that G6
belongs to the NlpC/P60 superfamily of enzymeswith a catalytic
Cys–His dyad and a predicted modified papain fold (Ananthara-
man and Aravind, 2003). Furthermore, G6 and its poxvirus
orthologs belong to a branch of this diverse protein superfamily
that is characterized by a circularly permuted version of the
papain fold such that the order of the motifs containing the
predicted catalytic Cys andHis residues is reversed in the protein
sequences compared to the canonical papain fold. The X-ray
structure of the uncharacterized Escherichia coli protein YiiX,
which also belongs to the branch of the NlpC/P60 superfamily
with a circular permutation of the catalytic domain, has been
solved as part of one of the Structural Genomics projects (PDB
2IF6). Examination of the structure of YiiX supports the
presence of a permuted papain-like fold and demonstrates the
juxtaposition of the predicted catalytic His and Cys, reinforcing
the prediction of a peptidase or acyltransferase activity for this
entire group of proteins (EVK, unpublished observations).
Unexpectedly, the sequences of G6 and its orthologs in other
poxviruses showed by far the greatest sequence similarity with a
group of bacterial permuted NlpC/P60 proteins as opposed to
eukaryotic members of this group (Fig. 1). The affinity of the
poxvirus proteins with bacterial homologs was supported by
phylogenetic analysis as the poxvirus proteins clustered with a
distinct family of bacterial proteins to the exclusion of euka-ryotic homologs (Anantharaman and Aravind, 2003). Thus, the
ancestor of the G6 gene might have been acquired from a
bacterial source at the onset of poxvirus evolution.
Another notable feature of poxvirus orthologs of G6 is the
conservation of an additional Cys located 7 amino acids down-
stream of the first in seven genera of chordopoxviruses, with a
replacement by Ser in capripoxviruses and entomopoxviruses.
This second Cys is also present in many other sequences of
permuted NlpC/P60 proteins (Fig. 1 and data not shown). In the
animal lecithin retinol acyltransferase, which is a member of
this group, albeit quite distant from G6, both cysteine residues
have been shown to be important for the acyltransferase activity
(Mondal et al., 2000), suggesting a mechanistically similar
activity for the poxvirus proteins. Thus, based on the pronoun-
ced sequence similarity with other proteins of the NlpC/P60
superfamily, the most likely activity for G6 is peptidase or
acyltransferase. Unlike lecithin retinol acyltransferase but simi-
lar to some of the bacterial homologs, G6 and its orthologs in
other poxviruses are not predicted to contain transmembrane
domains or signal peptides, which suggests a cytosolic locali-
zation for these proteins.
G6 is synthesized after viral DNA replication and is
incorporated into the virion
To establish that the G6 protein is expressed and to determine
the kinetics of G6 accumulation during the virus life cycle, we
constructed a recombinant VACV in which the G6R gene re-
mained under the control of its native promoter and DNA
encoding a V5 epitope tag replaced the last eleven G6R codons,
which are not highly conserved. This construction also included
the enhanced green fluorescent protein (EGFP) gene under the
control of the VACV late P11 promoter downstream of the
modified G6R gene to allow screening for recombinant virus
plaques (Fig. 2A). The recombinant virus, designated vG6-V5/
Table 1
Description of recombinant vaccinia viruses
Recombinant virus Parent Description
vG6-V5/EGFP Strain WR V5-tag replacing last 11
codons of G6R+EGFP reporter
vG6i vT7lacOI Inducible G6R with V5-tag
vΔG6 Strain WR G6R replaced by EGFP reporter
vG6-rev vΔG6 Unmutated G6R
vG6−1 and vG6−2 vΔG6 TAA replacing 24th and 25th
codons of G6R
vG6/C-S vΔG6 Cys 109 of G6R replaced by Ser
vG6-V5 vΔG6 V5 epitope tag replacing last 11
codons of G6R
509T.G. Senkevich et al. / Virology 374 (2008) 506–514EGFP (Table 1), was isolated and characterized. Neither the
virus yield nor the plaque size of the recombinant virus in BS-C-
1 cells was impaired compared to wild type virus (data not
shown). The synthesis of the G6-V5 protein was monitored
during the VACV replication cycle in the presence or absence of
cytosine arabinoside (AraC), an inhibitor of DNA replication.
Cell lysates, as well as a sample of purified vG6-V5/EGFP
virus, were analyzed by sodium dodecylsulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and western blotting. A ∼20-
kDa band, corresponding to the expected size of G6-V5, was
detected in cell extracts starting at 6 h after infection and
accumulated between 8 and 24 h (Fig. 2B). For comparison, a
typical late virion protein A3 was analyzed in the same blot
(after stripping the filter) with the corresponding antibody.
Essentially, the same kinetics of protein accumulation was ob-
served (Fig. 2B). The timing of G6 synthesis and inhibition by
AraC was consistent with G6 being a late protein. The G6
protein was also detected in purified virions (Fig. 2B). In ad-
dition, the ratios of G6 and A3 in cell extracts and purified
virions were similar (not shown), indicating that G6 is a true
virion component, and not a contaminant.
Localization of G6 in the virus particle
The pattern of extraction of proteins from VACV virions with
detergents typically correlates with their localization on theFig. 3. Extraction of G6-V5 from virus particles. Aliquots of sucrose gradient-
purified vG6-V5/EGFP virions were resuspended in 50 mM Tris pH 8.0 with the
addition of: 1) 1%NP40; 2) 1% NP40, 10 mMDTT; 3) 1%NP40, 250 mMNaCl;
4) 250mMNaCl, 0.2%deoxycholate (DOC), 10mMDTTand incubated 30min at
room temperature. The soluble (S) and insoluble (P) fractions were separated by
centrifugation and analyzed by western blotting with anti-V5, anti-A3 polyclonal
antibody or anti-L1 polyclonal antibody as described in the legend to Fig. 2.surface or interior of the virus particle. Fig. 3 shows the parti-
tioning of A3, a structural component of the core, the virion
membrane protein L1 and G6 in soluble and insoluble fractions of
virions. The partitioning of G6 mostly in the detergent-insoluble
fraction of virions suggests that it is an internal component, like
A3 rather than L1. UnlikemanyVACVenzymes, G6 could not be
extracted appreciably with deoxycholate and in this respect was
similar to A3 (Fig. 3).
The localization of G6-V5 in the virus particle was further
investigated by electron microscopy with anti-V5 antibody and
protein A conjugated to gold spheres. There was no staining of cell
organelles (not shown). Gold particles were associated with the
interior of immature virus particles (Fig. 4A), and mostly between
the central core and membrane of mature virions (Figs. 4B, C). In
control (V5-untagged) VACV-infected cells, only occasional,
widely dispersed gold particles were observed (data not shown).
G6 is not required for virus growth in cell culture
The conservation of G6 in all poxviruses suggested an
essential role in virus reproduction. To investigate the function
of G6 protein in the virus life cycle, we used a strategy for
making conditionally lethal mutants that is applicable to VACVFig. 4. Immunogold labeling of virus particles with anti-V5 antibody. BS-C-1
cells infected with vG6-V5/EGFP were fixed 20 h post-infection with
paraformaldehyde, cryosectioned, and incubated with a mouse MAb to the
V5-tag, rabbit antibody to mouse IgG, and then with 10-nm-diameter gold
particles conjugated to protein A. (A) Field containing immature virions. (B, C)
Fields containing mature virions under different magnifications.
Fig. 5. Multi-step virus growth. BS-C-1 cells were infected with 10−4 PFU/cell
of vΔG6 orWR virus, samples were collected every 24 h for 6 consecutive days,
and virus titers were determined by plaque assay.
Table 2
Cell cultures used for analysis of vΔG6R replication
Cell lines
Abbreviation Species Source Morphology
BS-C-1 Monkey, African green Kidney Epithelial
HeLa S3 Human Cervix; adenocarcinoma Epithelial
RK13 Rabbit Kidney Epithelial
MRC-5 Human Lung Fibroblast
FRhL Monkey, Rhesus Lung, fetal Fibroblast
Primary cell cultures
HFF Human Foreskin Fibroblast
HEKn Human Neonatal foreskin Keratinocyte
CEF Chicken Embryo Fibroblast
HFF, primary human foreskin fibroblasts; HEKn, primary human neonatal
foreskin keratinocytes; CEF, chick embryo fibroblasts.
Fig. 6. Formation of vΔG6 and WR plaques on chick embryo fibroblasts (CEF)
and BS-C-1 cells. BS-C-1 and CEF cells were infected with vΔG6 and VACV
WR and after 48 h stained with anti-VACV polyclonal antibody followed by
horseradish peroxidase-conjugated secondary antibody.
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recombinant VACV (vG6i) was constructed in which transcrip-
tion of the G6R gene was placed under the control of a bac-
teriophage T7 promoter and was regulated by the E. coli lac
operator system and T7 RNA polymerase. This mutant could
express detectable amounts of V5-tagged G6 only in the pre-
sence of inducer IPTG. Unexpectedly, vG6i plaque formation
did not show dependence on the inducer (not shown). Similar
results were obtained with several other recombinant viruses
with different orientations of G6R regulated by E. coli lac
operator, suggesting that the G6 protein is not essential for virus
reproduction or that extremely low levels suffice.
To distinguish between the above possibilities, we attempted
to replace the G6R gene except for the last 33 bp, which
overlaps the adjacent G7L gene, with the gene encoding EGFP
under the control of the VACV early-late synthetic promoter
(Chakrabarti et al., 1997), by homologous recombination.
EGFP provided the ability to screen even for very small recom-
binant virus plaques by fluorescence microscopy and has ad-
vantages over antibiotic selection (Da Fonseca and Moss 2003).
If G6R was essential, we should not be able to isolate such a
recombinant virus. However, green plaques were readily
detected and the virus was clonally purified. DNA sequencing
confirmed that the recombinant virus, vΔG6 (Table 1), retained
only the expected last 33 bp of the G6R ORF. Neither the virus
yield nor the plaque size of the recombinant virus was impaired
in BS-C-1 cells compared to the wild type virus. In an attempt to
detect even a slight difference in the replication of vΔG6 and
wild type virus, we infected BS-C-1 cells with only 10−4 PFU/
cell and monitored the growth of viruses over multiple cycles
for 6 days. Again, however, no difference was observed (Fig. 5).
We then attempted to find a cell line or a primary cell culture
that would be less permissive for the vΔG6. Eight different
cultures were tested (Table 2) and some impairment of vΔG6
growth was detected only in primary chick embryo fibroblasts
(CEF). In this culture, the mutant virus produced 3–5 fold fewer
plaques of smaller size than in other cultures (Fig. 6). To
ascertain that the defect in CEF was due to the absence of the G6protein rather than an effect of the EGFP gene expressed from
the strong early/late promoter, we replaced the original insert of
EGFP with an inactivated copy of G6R. The inactivation was
achieved by engineering two stop codons in place of the codons
for amino acids 24 and 25 of G6. The new virus, vG6−, con-
tained no foreign sequences and differed from the wild type by
only two nucleotides within the G6R gene sequence. In parallel,
the EGFP insert was replaced by a wild type copy of G6 to
produce the recombinant virus vG6-rev. This revertant virus
was used as a control to ensure that the phenotype of vΔG6 had
not resulted from an undetected, spontaneous mutation in ano-
ther part of the genome. Unexpectedly, we found that EGFP
expression in the G6R locus did affect virus growth in CEF. The
vG6-rev and vG6− both grew better in CEF than vΔG6, which
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experiment, we inserted the EGFP gene expressed under the
control of the early/late synthetic promoter after the G6R gene.
The growth of the resultant recombinant virus was impaired in
CEF similar to vΔG6 (data not shown). Thus, the insertion of
EGFP controlled by early/late synthetic promoter into G6R
locus impaired the growth of VACV in CEF. Notably, this was
not the case for another locus in the VACV genome, i.e., when
EGFP-coding sequence was inserted downstream of the D4R
gene (TGS, unpublished observations). Thus, the effect of the
G6 deletion on virus reproduction in CEF was due, primarily, to
the expression of EGFP in the G6R locus, possibly by trans-
cription through the essential G7L gene (Szajner et al., 2003)
and reducing expression of the latter, rather than by inactivation
of G6R. Although there was a very slight, less than twofold
remaining difference between the growth of vG6-rev and vG6−
(not shown), this was insufficient for more detailed analysis.Fig. 7. Weight loss and survival after intranasal infection of mice with VACVmutants
PFU of the indicated viruses. vG6-rev contains unmutated G6; vG6−1 and vG6−2 are
25th codons of the G6R gene, respectively; vG6/C-S contains the G6R gene with cyst
11 codons of G6R. Error bars are shown. (B) Percentage of surviving animals infecAccordingly, we failed to identify a cell line where the G6
protein was required for virus growth.
G6 is important for VACV virulence in mice
When administered intranasally, the WR strain of VACV
causes weight loss and death in BALB/c mice primarily due to
pneumonia (Law et al., 2005; Williamson et al., 1990). Here we
compared virulence of 5 viruses (Table 1): VACVWR, vG6-rev,
vG6-V5 (not containing EGFP), vG6/C-S, and two independent
isolates of vG6− (vG6−1 and vG6−2), which have premature
termination codons as indicated above. In vG6/C-S, the
invariant cysteine in the predicted enzymatic active site of G6
was replaced with a serine. Studies with a mutant virus con-
taining a V5-tagged version of G6/C-S indicated that the single
amino acid substitution did not affect expression or stability of
the protein. The vG6-V5 virus was included in the experiment. (A) Percentage of original weight of mice in each group (n=5) infected with 104
two independent isolates containing stop codons (TAA) in place of the 24th and
eine 109 replaced by serine; vG6-V5 contains a V5 epitope tag replacing the last
ted with 104, 105 or 106 PFU of indicated viruses.
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lization of G6 in the virus particle. The virulence of the different
viruses was assessed by loss of weight and death, which usually
peaks between 7 and 10 days after intranasal infection. Mice
were weighed every day for 14 days and sacrificed if they lost
30% of their original body weight.
According to their virulence, the tested viruses fell into two
groups. The group with higher virulence included VACV WR,
vG6-rev and vG6-V5, whereas the less virulent group included
vG6−1, vG6−2 and vG6/C-S. There was no difference in virulence
within each group. At 104 PFU, mice infected with all 3 viruses of
the high-virulence group started to lose weight on day 5 and had
minimum weight (approximately 70–75% of the original weight)
on day 9.At this time∼50%of themice had died orwere sacrificed
and the others started to regain weight (Fig. 7A). At 104 PFU, the
less virulent viruses caused only a 5 to 10% weight loss and no
deaths (Fig. 7A). At 105 and 106 PFU, all mice infected with the
virulent group of viruses died, but many mice infected with 105
PFU of the less virulent group of viruses survived and started to
gainweight and some survived evenwith 106 PFU (Fig. 7B). Thus,
more severe weight losses and more deaths occurred in mice
infected with viruses containing intact G6 than with viruses that
lacked G6 or encoded mutated G6. The vG6-V5 was as virulent in
mice as the wild type, supporting our use of the V5-tagged protein
for localization studies. Importantly, the vG6/C-S mutant was atte-
nuated to the same degree as the G6 null mutants vG6−1 and
vG6−2. Together, these results show that the G6 protein, and likely
its predicted enzymatic activity, is important for virulence.
Discussion
Orthologs of VACV G6 protein are encoded in all sequenced
poxvirus genomes, which include representatives of 8 genera of
chordopoxviruses (and crocodilepox virus that is likely to be-
come the prototype of a new 9th genus) and two distantly
related entomopoxviruses. The majority of the genes that are
conserved in all poxviruses are essential for virus replication in
cell culture, i.e., the corresponding knockout mutants are lethal.
Only two exceptions are presently known, namely, the H6R
gene encoding a topoisomerase (Da Fonseca and Moss, 2003)
and the D10R gene encoding a decapping enzyme (Parrish and
Moss, 2006). However, growth of both of those knockout
viruses was severely impaired in all cells tested. Thus, the G6R
gene appears to be exceptional for a conserved gene in that
deletion had little or no consequence for replication in cell
culture. Nevertheless, deletion of G6R or mutation of the pre-
dicted active site impaired virulence after intranasal infection of
mice.
The present results appear to place G6R into the category of
poxvirus genes that are involved in virus–host interactions,
rather than replication per se. This finding is unexpected be-
cause G6R is conserved in both chordopoxviruses and ento-
mopoxviruses. Accordingly, the G6 protein might affect a
specific defense mechanism or other host function that is shared
by insects and vertebrates. Elucidation of the function of G6 in
infected animals has the potential to uncover unknown, evo-
lutionarily conserved mechanisms of virus–host interaction. Inthis regard, it seems intriguing that G6 shows a phylogenetic
affinity with bacterial (as opposed to eukaryotic) NlpC/P60
proteins; thus, a gene coding for a protein involved in virus–
host interaction might have been acquired horizontally from a
bacterium (perhaps, a symbiont of the host) at the onset of
poxvirus evolution. Previously, a similar origin has been infer-
red for the A22R gene, which encodes the Holiday junction
resolvase, a key enzyme of poxvirus DNA replication (Garcia
et al., 2000).
G6 was localized by immunoelectron microscopy within the
interior of immature virus particles and mostly between the
central core and membrane of mature virions. The so-called
lateral bodies occupy this space, though neither their function
nor their compositions have been determined. The viability of
G6R deletion mutants suggested that the packaging of the
protein in virus particles does not serve an important function in
assembly or virus infectivity. Packaging, however, could pro-
vide a means of introducing G6 into cells prior to viral gene
expression, as occurs with the herpesvirus tegument proteins,
which are located between the membrane and capsids and are
mostly involved in host–cell interactions (Roizman et al.,
2007). Interestingly, a conserved herpesvirus tegument protein
with a cysteine protease domain has been shown to have deu-
biquitinating activity (Kattenhorn et al., 2005; Schlieker et al.,
2005). Given the papain fold, evidence for a putative catalytic
cysteine in G6 required for full virulence, and the activities of
certain other members of the NlpC/P60 superfamily, the pos-
sibility exists that G6 is an isopeptidase that hydrolyzes a
specific viral or cellular substrate that has been modified with
ubiquitin, SUMO or another ubiquitin-like moiety.
Materials and methods
Cells and viruses
Cell lines were obtained from American Type Culture Col-
lection (Manassas, VA). Primary human foreskin fibroblasts
were provided by A. McBride (National Institute of Allergy and
Infectious Diseases, Bethesda, MD), primary human neonatal
foreskin keratinocytes were obtained from Cascade Biologics,
Inc. (Portland, OR). Primary chick embryo fibroblasts were
prepared from 10-day-old embryos and used in the first passage.
Standard procedures used for the preparation and maintenance
of BS-C-1 cells and for the propagation, titration and puri-
fication of VACV have been described previously (Earl et al.,
1998). All recombinant VACV were derived from the WR strain
(ATCC, VR-1354). On monolayers of BS-C-1 cells, VACV
produced clear plaques that were visible after staining with
crystal violet; on other cell monolayers, where plaques were less
visible, infected cell foci were detected by immunostaining with
anti-VACV antibody, followed by protein A conjugated to hor-
seradish peroxidase (Carroll and Moss, 1997).
Recombinant viruses
All recombinant VACV were constructed using a strategy
that involved transfection of a DNA segment with the sequence
513T.G. Senkevich et al. / Virology 374 (2008) 506–514of interest with 500 bp flanks to allow homologous recombina-
tion. The respective DNA sequence in each case was assembled
using overlapping polymerase chain reaction as described prev-
iously (Senkevich et al., 2000). vG6-V5/EGFP contains the
G6R gene at its original position with a C-terminal V5 epitope
tag sequence replacing the last 11 codons followed by the
VACV strong late F17R gene promoter (P11) regulating the EGFP
gene. In vΔG6, the G6R gene, except for the last 33 codons,
was replaced with the EGFP gene preceded by an early/late
synthetic vaccinia promoter. vG6-rev, vG6−1, vG6−2, vG6/C-S
and vG6-V5 were made from vΔG6 by replacing the EGFP
gene with the respective DNA and screening for non-fluores-
cent plaques on the background of green, fluorescent plaques of
the parental vΔG6. vG6-rev contains unmutated G6; vG6−1
and vG6−2 are two independent isolates containing stop codons
(TAA) in place of the 24th and 25th codons of the G6R gene,
respectively; vG6/C-S contains the G6R gene with cysteine 109
replaced by serine; vG6-V5 contains a V5 epitope tag replacing
the last 11 codons of G6R. The modified DNA segment of each
virus was PCR-amplified and sequenced.
Transmission electron microscopy
BS-C-1 cells were infected with 10 PFU of virus per cell for
1 h at 37 °C, unadsorbed virus was removed by washing and the
incubation continued for a total of 20 h. Cells were fixed with
4% paraformaldehyde/0.05% glutaraldehyde in 0.1 M phos-
phate buffer for 1 h at room temperature and incubated in 10%
gelatin at 37 ° C. The cell pellet was collected by centrifugation,
solidified on ice, cut at 4 °C into small cubes infiltrated with
2.3 M sucrose in 0.1 M phosphate buffer, frozen on pins in
liquid nitrogen, cut into 70-nm sections on a Leica Ultracut FCS
microtome (Wetzlar, Germany). Cryosections were picked up
on grids, thawed, washed free of sucrose, and stained with a
mAb to a V5 epitope tag (Invitrogen, Carlsbad, CA) followed
by rabbit anti-mouse IgG and protein A conjugated to 10-nm
gold spheres (Department of Cell Biology, Utrecht University
School of Medicine, Utrecht, The Netherlands). Sections were
analyzed on a transmission electron microscope (model Philips
CM100; FEI Co., Hillsboro, OR).
Antibodies
Anti-V5 Mab (Invitrogen) was used for electron microscopy
and anti-V5 horseradish peroxidase-conjugated Mab (Invitro-
gen) for western blot analysis. The following rabbit polyclonal
antibodies against VACV proteins were used for western blot
analysis: anti-L1 (R180), provided by G. Cohen and R. Eisen-
berg (University of Pennsylvania), which was raised against
secreted baculovirus-expressed L1 protein (Aldaz-Carroll et al.,
2005), and anti-p4b/4b (R. Doms and B. Moss, unpublished).
Determination of virus virulence in mice
Groups of 7-week-old female BALB/c mice (5 per group)
were anesthetized and inoculated intranasally with 104, 105 or
106 PFU of purified wild type or recombinant VACV in 20 μl ofphosphate buffered saline–0.05% bovine serum albumin. Virus
titers were determined on the day of challenge to confirm the
virus dose. Mice were weighed daily for 14 days and sacrificed
if they lost 30% of their original body weight according to
institutional guidelines. The virulence of the different viruses
was assessed by loss of weight and death, which occurred
between 7 and 10 days after infection.
Protein sequence analysis
The non-redundant protein sequence database (NCBI, NIH,
Bethesda, MD) was searched using the BLASTP program, and
iterative searches were performed using the PSI-BLAST program
(Altschul et al., 1997). Multiple sequence alignments were con-
structed using the CLUSTAL-X program (Thompson et al., 1997).
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